Chemoinformaics analysis of 2-Deoxy-20-Hydroxyecdysone-22-Benzoate
| Molecular Weight | 480.642 | nRot | 5 |
| Heavy Atom Molecular Weight | 436.29 | nRig | 21 |
| Exact Molecular Weight | 480.309 | nRing | 4 |
| Solubility: LogS | -2.727 | nHRing | 0 |
| Solubility: LogP | 1.317 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 80.0429 |
| nHD | 6 | BPOL | 45.0091 |
| QED | 0.331 |
| Synth | 5.338 |
| Natural Product Likeliness | 3.209 |
| NR-PPAR-gamma | 0.129 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.076 |
| HIA | 0.789 |
| CACO-2 | -4.967 |
| MDCK | 0.0000118 |
| BBB | 0.903 |
| PPB | 0.742531 |
| VDSS | 0.935 |
| FU | 0.166455 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.202 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.742 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.425 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.117 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.383 |
| CL | 2.859 |
| T12 | 0.21 |
| hERG | 0.034 |
| Ames | 0.092 |
| ROA | 0.822 |
| SkinSen | 0.032 |
| Carcinogencity | 0.022 |
| EI | 0.008 |
| Respiratory | 0.42 |
| NR-Aromatase | 0.739 |
| Antiviral | Yes |
| Prediction | 0.700043 |